Relapse after allogeneic stem cell transplantation: Is it time for routine HLA loss testing?
Allogeneic hematopoietic stem cell transplantation (allo-HCT) remains one of the few potentially...
News | June 26, 2025
Devyser launches Devyser HLA Loss: A high-precision NGS assay for post-transplant researchNews | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in China
.png)
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patients
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Devyser Accept cfDNA demonstrates high performance in newly published peer-reviewed article
Devyser’s NGS products for monitoring of kidney and stem cell transplant patients receive IVDR approvals
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...